Lettner Johannes D, Kuesters Simon, Fichtner-Feigl Stefan, Biesel Esther A, Chikhladze Sophia, Wittel Uwe A
Department of General and Visceral Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg.
Department of General and Visceral Surgery, Medical Center - Fürst Stirum Hospital Bruchsal.
Int J Surg. 2024 Nov 1;110(11):7106-7111. doi: 10.1097/JS9.0000000000001949.
Surgery remains the only curative treatment option for pancreatic head cancer. Laparoscopic surgical techniques are increasingly used, in line with the development of visceral surgery as a whole. The success of surgery is measured by the oncological outcome. Aim of this study is to evaluate the oncological outcome and survival after laparoscopic assisted resection of the pancreatic head compared to open surgery for ductal adenocarcinoma.
Data were collected in a prospectively maintained database. Perioperative and oncological outcomes of 182 laparoscopic pancreatic head resections for ductal carcinoma were compared with 585 open pancreatic head resections. The laparoscopic procedures were performed between 2010 and 2022, the open procedures between 2002 and 2022.
Laparoscopic procedure was significantly superior in terms of intraoperative blood loss (575 vs. 600 ml, P =0.021) and operative time (413 vs. 427 min, P =0.033). Tumor size (25 vs. 27 mm, P =0.028), need for portal vein resection ( P =0.009) and blood transfusion ( P =0.004) were significantly greater in the open group ( P =0.009). The resection margin remained negative significantly more often in the laparoscopic group (159 [87%] vs. 449 [77%], P <0.001). There was no difference in postoperative mortality and morbidity. Postoperative survival at 5 years was significantly better in the laparoscopic group (37 vs. 15%, P <0.001).
In our cohort, patients who underwent hybrid laparoscopic resection of pancreatic head cancer showed a significantly improved oncological outcome. Most of these effects are due to selection bias, which is not captured by the clinical parameters used to date. Our results highlight the need for additional prognostic factors in pancreatic cancer.
手术仍然是胰头癌唯一的治愈性治疗选择。随着整个腹部外科手术的发展,腹腔镜手术技术的应用越来越广泛。手术的成功与否以肿瘤学结局来衡量。本研究的目的是评估与开腹手术相比,腹腔镜辅助胰头切除术治疗导管腺癌后的肿瘤学结局和生存率。
数据收集于一个前瞻性维护的数据库。将182例腹腔镜胰头导管癌切除术的围手术期和肿瘤学结局与585例开腹胰头切除术进行比较。腹腔镜手术在2010年至2022年间进行,开腹手术在2002年至2022年间进行。
腹腔镜手术在术中出血量(575 vs. 600 ml,P =0.021)和手术时间(413 vs. 427分钟,P =0.033)方面明显更优。开腹组的肿瘤大小(25 vs. 27 mm,P =0.028)、门静脉切除需求(P =0.009)和输血需求(P =0.004)明显更高(P =0.009)。腹腔镜组切缘阴性的情况明显更常见(159例[87%] vs. 449例[77%],P <0.001)。术后死亡率和发病率无差异。腹腔镜组5年术后生存率明显更高(37% vs. 15%,P <0.001)。
在我们的队列中,接受胰头癌腹腔镜混合切除术的患者肿瘤学结局明显改善。这些影响大多归因于选择偏倚,而这是目前所用临床参数未捕捉到的。我们的结果凸显了胰腺癌中额外预后因素的必要性。